N-6-cyclopentyl-3'-substituted-xylofuranosyladenosines: A new class of non-xanthine adenosine A(1) receptor antagonists

被引:18
|
作者
VanCalenbergh, S
vonFrijtag, JK
Kunzel, D
Blaton, NM
Peeters, OM
Rozenski, J
VanAerschot, A
DeBruyn, A
DeKeukeleire, D
Ijzerman, AP
Herdewijn, P
机构
[1] STATE UNIV GHENT,MED CHEM LAB,FFW,B-9000 GHENT,BELGIUM
[2] LEIDEN AMSTERDAM CTR DRUG RES,DIV MED CHEM,NL-2300 RA LEIDEN,NETHERLANDS
[3] KATHOLIEKE UNIV LEUVEN,FAC PHARMACEUT SCI,LAB ANALYT CHEM & MED PHYSICOCHEM,B-3001 LOUVAIN,BELGIUM
[4] KATHOLIEKE UNIV LEUVEN,REGA INST,MED CHEM LAB,B-3001 LOUVAIN,BELGIUM
关键词
D O I
10.1021/jm970176k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The present study explores the C-3' site of the 3-deoxy-3-xylofuranosyl ring of nucleoside analogues with an adenine or N-6-cyclopentyladenine (CPA) base moiety and evaluates the effect on adenosine receptor affinity. Two series of sugar-modified adenosines, i.e., 3'-amido-3'-deoxyadenosines and 3'-amidated 3'-deoxyxylofuranosyladenines, were synthesized and tested for their affinity at A(1) and A(2a) receptors in rat brain cortex and rat striatum, respectively. The modest affinity found in the ''xylo series'' prompted us to synthesize the corresponding N-6-cyclopentyl derivatives, which proved to be well accommodated by the A(1) receptors with potencies in the lower nanomolar range. This represents a new perspective in the purinergic field. The absence of a GTP-induced shift, i.e., the ratio between the affinities measured in the presence and absence of 1 mM GTP indicates an antagonistic behavior of this new class of CPA analogues.
引用
收藏
页码:3765 / 3772
页数:8
相关论文
共 50 条
  • [1] Non-xanthine antagonists for the adenosine A1 receptor
    Chang, LCW
    Brussee, J
    IJzerman, AP
    CHEMISTRY & BIODIVERSITY, 2004, 1 (11) : 1591 - 1626
  • [2] 3′-amidated 3′-deoxyxylofuranose analogues of N6-cyclopentyladenosines:: A new class of non-xanthine antagonists at the adenosine A1 receptor.
    Van Calenbergh, S
    IJzerman, AP
    Herdewijn, P
    NUCLEOSIDES & NUCLEOTIDES, 1998, 17 (9-11): : 1571 - 1576
  • [3] Novel selective non-xanthine A3 adenosine receptor antagonists
    Jacobson, MA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U888 - U888
  • [4] Novel non-xanthine adenosine A1 receptor antagonist
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1999, 4 (07) : 333 - 334
  • [5] NON-XANTHINE HETEROCYCLES - ACTIVITY AS ANTAGONISTS OF A1-ADENOSINE AND A2-ADENOSINE RECEPTORS
    DALY, JW
    HONG, O
    PADGETT, WL
    SHAMIM, MT
    JACOBSON, KA
    UKENA, D
    BIOCHEMICAL PHARMACOLOGY, 1988, 37 (04) : 655 - 664
  • [6] N6-SUBSTITUTED 9-METHYLADENINES - A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS
    UKENA, D
    PADGETT, WL
    HONG, O
    DALY, JW
    DALY, DT
    OLSSON, RA
    FEBS LETTERS, 1987, 215 (02) : 203 - 208
  • [7] Process development of a novel non-xanthine adenosine A1 receptor antagonist
    Zanka, A
    Uematsu, R
    Morinaga, Y
    Yasuda, H
    Yamazaki, H
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1999, 3 (06) : 389 - 393
  • [8] QSAR and docking analysis of A2B adenosine receptor antagonists based on non-xanthine scaffold
    Mansourian, Mahboubeh
    Fassihi, Afshin
    Saghaie, Lotfollah
    Madadkar-Sobhani, Armin
    Mahnam, Karim
    Abbasi, Maryam
    MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (01) : 394 - 407
  • [9] QSAR and docking analysis of A2B adenosine receptor antagonists based on non-xanthine scaffold
    Mahboubeh Mansourian
    Afshin Fassihi
    Lotfollah Saghaie
    Armin Madadkar-Sobhani
    Karim Mahnam
    Maryam Abbasi
    Medicinal Chemistry Research, 2015, 24 : 394 - 407
  • [10] FK453: A novel non-xanthine adenosine A(1) receptor antagonist as diuretic
    Terai, T
    Kusunoki, T
    Kita, Y
    Akahane, A
    Shiokawa, Y
    Kohno, Y
    Horiai, H
    Uehara, Y
    Yoshida, K
    CARDIOVASCULAR DRUG REVIEWS, 1997, 15 (01): : 44 - 58